Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with principal activities in Venture Capital, Merchant Banking and Media. With over $850 million of capital under management, the Burrill Venture Capital Group invests in companies focused on biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology. In addition, the company publishes an annual book on the "State of the Industry" -- Biotech 2009-Life Sciences: Navigating the Sea Change – the 23rd annual report on the biotechnology industry is available from March 2009 and can be ordered at: www.burrillandco.com/resources. Burrill also publishes a range of biotechnology/life science newsletters and reports.